OxyContin: maintaining availability and efficacy while preventing diversion and abuse.
Regan
Judith J
JJ
Tennessee Department of Mental Health and Developmental Disabilities, Nashville, USA.
Alderson
Ann
A
D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use; D002908:Chronic Disease; D003415:Crime / Q000517:prevention & control; D004335:Drug and Narcotic Control / Q000458:organization & administration*; D006297:Health Services Accessibility / Q000458:organization & administration*; D006801:Humans; D009293:Opioid-Related Disorders / Q000517:prevention & control; D010098:Oxycodone / Q000009:adverse effects / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D013714:Tennessee; D014481:United States
D000701:Analgesics, Opioid; D010098:Oxycodone